ArticleHuman brain mapping2026
miniMORPH: A Morphometry Pipeline for Low-Field MRI in Infants.
Article in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Feasibility and Validity of Ultra-Low-Field MRI for Measurement of Regional Infant Brain Volumes in Structures Associated With Antenatal Maternal Anemia.Human brain mapping · 2026Article
- Antenatal maternal anaemia and infant brain structure: high-field (3 T) and ultra-low-field (64 mT) MRI findings from South Africa.Brain communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Ultra-low-field (ULF) MRI facilitates neuroimaging access, yet its application in early infancy is constrained by low resolution and contrast, and the limited suitability of existing segmentation tools. In this work we introduce and validate miniMORPH, an open-source pipeline for automated brain volumetry from 0.064T T2-weighted MRI acquired across infancy and toddlerhood. ULF scans were acquired from infants aged 2 to 27 months across two cohorts in South Africa and Uganda. Age-specific templates and priors were used to segment major brain tissues and substructures. Validation used two high-field (HF) references: (i) expert manual HF segmentations for key ROIs across ages, and (ii) automated HF segmentations from SuperSynth on paired HF-ULF scans. We quantified (a) between-subject ordering across modalities using Pearson's correlation (r) and (b) systematic scaling differences using percentage error (PE) and time-corrected percentage error (CPE), stratifying performance by cohort and age. Face validity was also tested via mixed-effects models of age, sex, and birthweight. miniMORPH generated anatomically plausible segmentations of major brain regions across infancy. In paired HF-ULF comparisons, between-subject ordering was generally preserved across many ROIs, with stronger correspondence in the South African cohort than in the Ugandan cohort at 12 months. Systematic scaling offsets were most evident in CSF-rich or boundary-sensitive compartments, with consistently negative CPE for ventricles and cerebellum. Performance varied with age, showing the greatest variability at 3 months. miniMORPH successfully captured regional age-related growth trajectories. Sex-dependent volumetric differences were widespread but attenuated after intracranial volume correction. Low birthweight infants exhibited reduced regional volumes and altered growth trajectories. Taken together, these findings indicate that miniMORPH enables volumetric analysis of ULF infant MRI and preserves between-subject variation suitable for developmental and group analyses. ROI- and cohort-specific offsets, particularly in CSF-rich regions, may require calibration when absolute volumes are needed. The pipeline is openly available at https://github.com/UNITY-Physics/fw-minimorph.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.